SCHEMBL798803

SCHEMBL798803

CCOC(=O)N(CC)c1cccc(C(F)(F)F)c1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.54
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2C19 P33261 1/20 0.52
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
POLQ O75417 1/20 0.50
MAPT P10636 1/20 0.50
ALOX15 P16050 1/20 0.49
LTB4R2 Q9NPC1 2/20 0.48
HTT P42858 2/20 0.46
ALDH1A1 P00352 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46
HPGD P15428 1/20 0.46
THRB P10828 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Flubanilate SCHEMBL1404126 0.87 ALOX15 (0.46) TSHRCYP1A2CYP3A4CYP2C19MEN1
SCHEMBL10870789 0.87 ALOX15 (0.48) TSHRCYP1A2CYP3A4CYP2C19MEN1
Flubanilate SCHEMBL121907 0.86 ALOX15 (0.45) TSHRCYP1A2CYP3A4CYP2C19MEN1
SCHEMBL9224528 0.85 TSHR (0.50) TSHRCYP1A2CYP2C19MEN1KMT2A
SCHEMBL9357893 0.84 LMNA (0.57) TSHRMEN1KMT2APOLQMAPT
SCHEMBL2095059 0.82 HPGD (0.50) CYP1A2CYP3A4CYP2C19MEN1KMT2A
SCHEMBL10871800 0.81 ALOX15 (0.47) CYP1A2CYP3A4CYP2C19MEN1KMT2A
SCHEMBL27919587 0.81 POLQ (0.55) TSHRMEN1KMT2APOLQMAPT
SCHEMBL6227930 0.80 ALDH1A1 (0.53) TSHRCYP1A2CYP3A4CYP2C19MEN1
SCHEMBL1400828 0.77 ALDH1A1 (0.63) TSHRCYP1A2CYP2C19MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2627648-A1 17aHYDROXYLASE/C17,20-LYASE INHIBITORS Novartis AG (CH) 2013-08-21 EP disclosed
WO-2012035078-A1 17α-HYDROXYLASE/C17,20-LYASE INHIBITORS NOVARTIS AG (CH) 2012-03-22 WO disclosed